Search

Your search keyword '"Ohkawara, Tomoharu"' showing total 151 results

Search Constraints

Start Over You searched for: Author "Ohkawara, Tomoharu" Remove constraint Author: "Ohkawara, Tomoharu"
151 results on '"Ohkawara, Tomoharu"'

Search Results

3. Leucine-rich α2-glycoprotein as a useful biomarker for evaluating disease activity in rheumatoid arthritis.

4. Anti-glypican-1 antibody–drug conjugate is a potential therapy against pancreatic cancer

5. TAS-116 inhibits oncogenic KIT signalling on the Golgi in both imatinib-naïve and imatinib-resistant gastrointestinal stromal tumours

7. Tumor cell‐expressed lipolysis‐stimulated lipoprotein receptor negatively regulates T‐cell function

8. Tumor cell‐expressed lipolysis‐stimulated lipoprotein receptor negatively regulates T‐cell function.

9. SOCS1 gene therapy has antitumor effects in imatinib-resistant gastrointestinal stromal tumor cells through FAK/PI3 K signaling

10. Nano-particulate Toll-like Receptor 9 Agonist Potentiates the Antitumor Activity of Anti-Glypican-1 Antibody

11. Supplementary Methods and Figures S1-S2 from Intratumoral Delivery of an Adenoviral Vector Carrying the SOCS-1 Gene Enhances T-Cell–Mediated Antitumor Immunity By Suppressing PD-L1

12. Data from Intratumoral Delivery of an Adenoviral Vector Carrying the SOCS-1 Gene Enhances T-Cell–Mediated Antitumor Immunity By Suppressing PD-L1

13. Figure S1 from SOCS1 Gene Therapy Improves Radiosensitivity and Enhances Irradiation-Induced DNA Damage in Esophageal Squamous Cell Carcinoma

14. Data from SOCS1 Gene Therapy Improves Radiosensitivity and Enhances Irradiation-Induced DNA Damage in Esophageal Squamous Cell Carcinoma

15. Supplementary Figure Legends from SOCS1 Gene Therapy Improves Radiosensitivity and Enhances Irradiation-Induced DNA Damage in Esophageal Squamous Cell Carcinoma

23. Correction: Lipolysis-stimulated lipoprotein receptor overexpression is a novel predictor of poor clinical prognosis and a potential therapeutic target in gastric cancer

26. Luteolin, a flavonoid, inhibits AP-1 activation by basophils

31. iTRAQ-based proteomic identification of leucine-rich (alpha)-2 glycoprotein as a novel inflammatory biomarker in autoimmune diseases

33. Gene therapy with SOCS1 induces potent preclinical antitumor activities in oral squamous cell carcinoma.

37. TAS-116 inhibits oncogenic KIT signalling on the Golgi in both imatinib-naïve and imatinib-resistant gastrointestinal stromal tumours

38. Intratumoral Delivery of an Adenoviral Vector Carrying the SOCS-1 Gene Enhances T-Cell–Mediated Antitumor Immunity By Suppressing PD-L1

39. Lipolysis-stimulated lipoprotein receptor overexpression is a novel predictor of poor clinical prognosis and a potential therapeutic target in gastric cancer

40. SOCS1 Gene Therapy Improves Radiosensitivity and Enhances Irradiation-Induced DNA Damage in Esophageal Squamous Cell Carcinoma

42. Anti‐glypican‐1 antibody‐drug conjugate exhibits potent preclinical antitumor activity against glypican‐1 positive uterine cervical cancer

44. Suppressor of cytokine signaling-1 gene therapy induces potent antitumor effect in patient-derived esophageal squamous cell carcinoma xenograft mice

45. Glypican-1 targeted antibody-based therapy induces preclinical antitumor activity against esophageal squamous cell carcinoma

46. Overexpression of glypican-1 implicates poor prognosis and their chemoresistance in oesophageal squamous cell carcinoma

48. 214

49. Serum leucine-rich alpha-2 glycoprotein is a disease activity biomarker in ulcerative colitis

50. The Influence of Excessive IL-6 Production In Vivo on the Development and Function of Foxp3+ Regulatory T Cells

Catalog

Books, media, physical & digital resources